| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Arkadip Choudhury, Avik Chakraborty, Amrit Kumar Bhattacharyy. A Rare Variant of Neuromyelitis Optica. The Journal of the Association of Physicians of India. vol 66. issue 10. 2019-08-16. PMID:31317719. |
absence of antibodies against aquaporin 4 (aqp4) in the serum in a case of neuromyelitis optica (nmo) is rare. |
2019-08-16 |
2023-08-13 |
Not clear |
| Arkadip Choudhury, Avik Chakraborty, Amrit Kumar Bhattacharyy. A Rare Variant of Neuromyelitis Optica. The Journal of the Association of Physicians of India. vol 66. issue 10. 2019-08-16. PMID:31317719. |
devic's disease or neuromyelitis optica (nmo) is an inflammatory disorder which is aggressive and characterized by recurrent attacks of optic neuritis (on) and myelitis. |
2019-08-16 |
2023-08-13 |
Not clear |
| W D Liu, M Y Yu, L B Jian. [The progress of research on the immune pathogenesis and biomarkers in optic neuritis related to neuromyelitis optica]. [Zhonghua yan ke za zhi] Chinese journal of ophthalmology. vol 55. issue 3. 2019-08-14. PMID:30841690. |
the idiopathic optic neuritis (ion) which is related to neuromyelitis optica (nmo) and neuromyelitis optica spectrum disorders (nmosd) is called optic neuritis related to neuromyelitis optica (nmo-on). |
2019-08-14 |
2023-08-13 |
Not clear |
| Chao-Lin Lee, Kai-Chen Wang, Shyi-Jou Chen, Chieh-Min Chen, Ching-Piao Tsai, Shao-Yuan Che. Repetitive intrathecal injection of human NMO-IgG with complement exacerbates disease severity with NMO pathology in experimental allergic encephalomyelitis mice. Multiple sclerosis and related disorders. vol 30. 2019-08-09. PMID:30825702. |
neuromyelitis optica (nmo) is recognized as a different cns autoimmune disease from multiple sclerosis (ms). |
2019-08-09 |
2023-08-13 |
mouse |
| Hiroshi Kuroda, Kazuo Fujihar. [Current Status and Prospects of Complement-Targeting Therapy for Neuromyelitis Optica]. Brain and nerve = Shinkei kenkyu no shinpo. vol 71. issue 6. 2019-08-07. PMID:31171754. |
neuromyelitis optica (nmo) is clinically characterized by severe optic neuritis and long myelitis; and is associated with aquaporin-4 immunoglobulin-g (aqp4-igg), an autoantibody directed against aquaporin-4 (aqp4), which is an astrocytic water channel protein. |
2019-08-07 |
2023-08-13 |
human |
| Eglė Sakalauskaitė-Juodeikienė, Giedrė Armalienė, Rasa Kizlaitienė, Loreta Bagdonaitė, Nataša Giedraitienė, Dalia Mickevičienė, Daiva Rastenytė, Gintaras Kaubrys, Dalius Jatuži. Detection of aquaporin-4 antibodies for patients with CNS inflammatory demyelinating diseases other than typical MS in Lithuania. Brain and behavior. vol 8. issue 11. 2019-07-22. PMID:30284401. |
neuromyelitis optica (nmo) is frequently associated with aquaporin-4 autoantibodies (aqp4-ab); however, studies of nmo in lithuania are lacking. |
2019-07-22 |
2023-08-13 |
Not clear |
| Nicolas Collongues, Estelle Ayme-Dietrich, Laurent Monassier, Jérôme de Sez. Pharmacotherapy for Neuromyelitis Optica Spectrum Disorders: Current Management and Future Options. Drugs. vol 79. issue 2. 2019-07-18. PMID:30623348. |
neuromyelitis optica (nmo) is an inflammatory and demyelinating disease of the central nervous system. |
2019-07-18 |
2023-08-13 |
Not clear |
| Lukmanee Tradtrantip, Tianjiao Duan, Michael R Yeaman, Alan S Verkma. CD55 upregulation in astrocytes by statins as potential therapy for AQP4-IgG seropositive neuromyelitis optica. Journal of neuroinflammation. vol 16. issue 1. 2019-07-15. PMID:30851734. |
neuromyelitis optica spectrum disorder (herein called nmo) is an inflammatory demyelinating disease that can be initiated by binding of immunoglobulin g autoantibodies (aqp4-igg) to aquaporin-4 on astrocytes, causing complement-dependent cytotoxicity (cdc) and downstream inflammation. |
2019-07-15 |
2023-08-13 |
Not clear |
| Masoud Etemadifar, Arefeh Izadi, Fatemeh Sabeti, Pegah Noorsharg. Anti-HSV-2 antibody in patients with MS and NMO. Multiple sclerosis and related disorders. vol 28. 2019-06-13. PMID:30641353. |
multiple sclerosis (ms) and neuromyelitis optica (nmo) are demyelinating disorders of the central nervous system. |
2019-06-13 |
2023-08-13 |
human |
| Krystian Obara, Marta Waliszewska-Prosół, Sławomir Budrewicz, Paweł Szewczyk, Maria Ejm. Severe course of neuromyelitis optica in a female patient with chronic C hepatitis. Neurologia i neurochirurgia polska. vol 52. issue 3. 2019-05-23. PMID:29454471. |
neuromyelitis optica (nmo) is a rare, disabling, recurring inflammatory demyelinating disease affecting the spinal cord and optic nerves with predominance in women. |
2019-05-23 |
2023-08-13 |
Not clear |
| Chunsheng Yang, Yang Yang, Li Ma, Guang-Xian Zhang, Fu-Dong Shi, Yaping Yan, Guoqiang Chan. Study of the cytological features of bone marrow mesenchymal stem cells from patients with neuromyelitis optica. International journal of molecular medicine. vol 43. issue 3. 2019-05-20. PMID:30628649. |
neuromyelitis optica (nmo) is a refractory autoimmune inflammatory disease of the central nervous system without an effective cure. |
2019-05-20 |
2023-08-13 |
human |
| Alexander Tan, Cole Hague, Benjamin M Greenberg, Lana Harde. Neuropsychological outcomes of pediatric demyelinating diseases: a review. Child neuropsychology : a journal on normal and abnormal development in childhood and adolescence. vol 24. issue 5. 2019-05-07. PMID:28637379. |
furthermore, literature on neuropsychological outcomes in pediatric acute disseminated encephalomyelitis (adem), neuromyelitis optica (nmo), and transverse myelitis (tm) is even more limited. |
2019-05-07 |
2023-08-13 |
Not clear |
| Gisa Ellrichmann, Jan Bolz, Maren Peschke, Alexander Duscha, Kerstin Hellwig, De-Hyung Lee, Ralf A Linker, Ralf Gold, Aiden Haghiki. Peripheral CD19 Journal of neurology. vol 266. issue 1. 2019-05-07. PMID:30377816. |
rituximab (rtx) has been in off-label use for the treatment of ms, neuromyelitis optica (nmo) and neuromyelitis optica spectrum disorder (nmosd) for > 10 years. |
2019-05-07 |
2023-08-13 |
Not clear |
| Stefania Rosito, Grazia Paola Nicchia, Claudia Palazzo, Anna Lia, Cinzia Buccoliero, Francesco Pisani, Maria Svelto, Maria Trojano, Antonio Friger. Supramolecular aggregation of aquaporin-4 is different in muscle and brain: correlation with tissue susceptibility in neuromyelitis optica. Journal of cellular and molecular medicine. vol 22. issue 2. 2019-04-29. PMID:29055082. |
neuromyelitis optica (nmo) is an autoimmune demyelinating disease of the central nervous system (cns) caused by autoantibodies (nmo-igg) against the water channel aquaporin-4 (aqp4). |
2019-04-29 |
2023-08-13 |
human |
| Ndiaga Matar Gaye, Maouly Fall, Alassane Mamadou Diop, Samy Mohamed Lemine Dadah, Mamadou Ka, Ousmane Cissé, Ngor Side Diagne, Marième Soda Diop-Sène, Adjaratou Dieynabou Sow, Anna Modji Basse-Faye, Mamadou Moustapha Sarr, Kamadore Touré, Lala Bouna Seck, Moustapha Ndiaye, Amadou Gallo Dio. Neuromyelitis optica spectrum disorders (NMO-SD) in a Sub-Saharan Africa country: A preliminary study of sixteen Senegalese cases. Multiple sclerosis and related disorders. vol 27. 2019-04-16. PMID:30388487. |
neuromyelitis optica (nmo) is an autoimmune disease of the central nervous system. |
2019-04-16 |
2023-08-13 |
Not clear |
| Masoud Etemadifar, Yalda Nikanpour, Amir Neshatfar, Fatemeh Sabet. Paraneoplastic neuromyelitis optica associated with fever of unknown origin as an early manifestation: A case report. Multiple sclerosis and related disorders. vol 27. 2019-04-16. PMID:30408758. |
tumors have been frequently reported to be associated with neuromyelitis optica (nmo). |
2019-04-16 |
2023-08-13 |
Not clear |
| Yiting Liu, Katherine S Given, Gregory P Owens, Wendy B Macklin, Jeffrey L Bennet. Distinct patterns of glia repair and remyelination in antibody-mediated demyelination models of multiple sclerosis and neuromyelitis optica. Glia. vol 66. issue 12. 2019-04-15. PMID:30240044. |
multiple sclerosis (ms) and neuromyelitis optica (nmo) are inflammatory demyelinating disorders of the central nervous system with evidence of antibody-mediated pathology. |
2019-04-15 |
2023-08-13 |
mouse |
| Fulin Gao, Bingyan Chai, Cheng Gu, Ruipeng Wu, Tong Dong, Yuping Yao, Yi Zhan. Effectiveness of rituximab in neuromyelitis optica: a meta-analysis. BMC neurology. vol 19. issue 1. 2019-04-15. PMID:30841862. |
neuromyelitis optica (nmo) is a severe inflammatory autoimmune disorder of the central nervous system and often results in paralysis or blindness. |
2019-04-15 |
2023-08-13 |
Not clear |
| Zhiguo Li, Jinrui Han, Honglei Ren, Cun-Gen Ma, Fu-Dong Shi, Qiang Liu, Minshu L. Astrocytic Interleukin-15 Reduces Pathology of Neuromyelitis Optica in Mice. Frontiers in immunology. vol 9. 2019-04-08. PMID:29616032. |
astrocyte loss induced by neuromyelitis optica (nmo)-igg and complement-dependent cytotoxicity (cdc) is the hallmark of nmo pathology. |
2019-04-08 |
2023-08-13 |
mouse |
| Melina V Jones, Michael Lev. Effect of CXCR2 Inhibition on Behavioral Outcomes and Pathology in Rat Model of Neuromyelitis Optica. Journal of immunology research. vol 2018. 2019-04-08. PMID:30648122. |
to reduce immune-mediated damage in a rat model of neuromyelitis optica (nmo) by blocking neutrophil migration using sch527123, a drug that inhibits cxcr2. |
2019-04-08 |
2023-08-13 |
rat |